News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Arsanis, Inc. Nominates Preclinical Candidate for Staphylococcus aureus Program


5/23/2013 11:05:35 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

VIENNA--(BUSINESS WIRE)--Arsanis Biosciences GmbH, a biotechnology company developing anti-infective human monoclonal antibodies, achieved a major milestone by nominating the preclinical development candidates for its lead program, a monoclonal antibody cocktail to prevent and treat severe hospital associated S. aureus infections.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES